Black Diamond Therapeutics (BDTX) Accumulated Depreciation & Amortization: 2018-2021
Historic Accumulated Depreciation & Amortization for Black Diamond Therapeutics (BDTX) over the last 2 years, with Sep 2021 value amounting to $246,000.
- Black Diamond Therapeutics' Accumulated Depreciation & Amortization rose 65.10% to $246,000 in Q3 2021 from the same period last year, while for Sep 2021 it was $796,000, marking a year-over-year increase of 53.67%. This contributed to the annual value of $164,000 for FY2020, which is 46.43% up from last year.
- Black Diamond Therapeutics' Accumulated Depreciation & Amortization amounted to $246,000 in Q3 2021, which was up 21.18% from $203,000 recorded in Q2 2021.
- Black Diamond Therapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $246,000 during Q3 2021, with a 5-year trough of $100,000 in Q4 2018.
- Its 3-year average for Accumulated Depreciation & Amortization is $164,250, with a median of $156,500 in 2020.
- Data for Black Diamond Therapeutics' Accumulated Depreciation & Amortization shows a peak YoY surged of 65.10% (in 2021) over the last 5 years.
- Quarterly analysis of 4 years shows Black Diamond Therapeutics' Accumulated Depreciation & Amortization stood at $100,000 in 2018, then increased by 12.00% to $112,000 in 2019, then soared by 46.43% to $164,000 in 2020, then surged by 65.10% to $246,000 in 2021.
- Its Accumulated Depreciation & Amortization was $246,000 in Q3 2021, compared to $203,000 in Q2 2021 and $183,000 in Q1 2021.